BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25158604)

  • 1. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination.
    Stothard JR; Stanton MC; Bustinduy AL; Sousa-Figueiredo JC; Van Dam GJ; Betson M; Waterhouse D; Ward S; Allan F; Hassan AA; Al-Helal MA; Memish ZA; Rollinson D
    Parasitology; 2014 Dec; 141(14):1947-61. PubMed ID: 25158604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New diagnostic tools in schistosomiasis.
    Utzinger J; Becker SL; van Lieshout L; van Dam GJ; Knopp S
    Clin Microbiol Infect; 2015 Jun; 21(6):529-42. PubMed ID: 25843503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Something old, something new: is praziquantel enough for schistosomiasis control?
    Secor WE; Montgomery SP
    Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities.
    Anderson RM; Turner HC; Farrell SH; Truscott JE
    Adv Parasitol; 2016; 94():199-246. PubMed ID: 27756455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration.
    Ross AG; Olveda RM; Li Y
    Lancet; 2015 May; 385(9983):2220-1. PubMed ID: 25467574
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis and treatment of schistosomiasis in children in the era of intensified control.
    Knopp S; Becker SL; Ingram KJ; Keiser J; Utzinger J
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1237-58. PubMed ID: 24127662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to set the agenda for schistosomiasis elimination.
    Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
    Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis.
    Stothard JR; Sousa-Figueiredo JC; Navaratnam AM
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):733-52. PubMed ID: 23879611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model.
    Stothard JR
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):325-32. PubMed ID: 19171359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis elimination by 2020 or 2030?
    Fenwick A; Jourdan P
    Int J Parasitol; 2016 Jun; 46(7):385-8. PubMed ID: 26907938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An achievable goal: control and elimination of schistosomiasis.
    Savioli L; Fenwick A; Rollinson D; Albonico M; Ame SM
    Lancet; 2015 Aug; 386(9995):739. PubMed ID: 26333971
    [No Abstract]   [Full Text] [Related]  

  • 12. Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal.
    Zoni AC; Catalá L; Ault SK
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004493. PubMed ID: 27007193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies.
    Tchuem Tchuenté LA; Rollinson D; Stothard JR; Molyneux D
    Infect Dis Poverty; 2017 Feb; 6(1):42. PubMed ID: 28219412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis.
    Amoah AS; Hoekstra PT; Casacuberta-Partal M; Coffeng LE; Corstjens PLAM; Greco B; van Lieshout L; Lim MD; Markwalter CF; Odiere MR; Reinhard-Rupp J; Roestenberg M; Stothard R; Tchuem Tchuenté LA; de Vlas SJ; van Dam GJ
    Lancet Infect Dis; 2020 Jul; 20(7):e165-e172. PubMed ID: 32595046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egypt's schistosomiasis control programme in the 1980s prepared the ground for the global elimination of schistosomiasis by 2030.
    Fenwick A
    Trans R Soc Trop Med Hyg; 2019 Jan; 113(1):1-3. PubMed ID: 31222345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes.
    Olveda DU; McManus DP; Ross AG
    Curr Opin Infect Dis; 2016 Dec; 29(6):595-608. PubMed ID: 27584590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do not forget schistosomiasis: a rare cause of changes in ejaculate.
    Knapper C; Morrell K; Lomax N
    Int J STD AIDS; 2012 Mar; 23(3):226. PubMed ID: 22581886
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of primary health care in the control of schistosomiasis. The experience in Riyadh, Saudi Arabia.
    Jarallah JS; al-Shammari SA; Khoja TA; al-Sheikh M
    Trop Geogr Med; 1993; 45(6):297-300. PubMed ID: 8116063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human schistosomiasis in the post mass drug administration era.
    Mutapi F; Maizels R; Fenwick A; Woolhouse M
    Lancet Infect Dis; 2017 Feb; 17(2):e42-e48. PubMed ID: 27988094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review.
    Torres-Vitolas CA; Dhanani N; Fleming FM
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009017. PubMed ID: 33465076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.